News for DefenceTherapeu (DTC.CN)

Defence Therapeutics Inc. , , a Canadian biopharmaceutical company developing novel immune-oncology vaccines and drug delivery technologies, is please to announce its participation to the Society of...

Defence Therapeutics Inc. , , a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce the successful completion of a...

Defence Therapeutics Inc. , one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces an amendment to the terms of 1,497,780 Class A Common share...

EQS-News: Defence Therapeutics Inc. / Key word: Miscellaneous ERFOLGE VON DEFENCE BEI SEINEM ACCUTOX®-ARM-VAKZIN ZUR KREBSBEKÄMPFUNG FÜHREN ZUR ENTWICKLUNG EINES...

EQS-News: Defence Therapeutics Inc. / Key word: Product Launch DEFENCE’S SUCCESSFUL RESULTS ON ITS  ACCUTOX® ANTI-CANCER ARMTM VACCINE CREATES A POTENT SECOND-GENERATION...

Defence Therapeutics Inc. , , one of the leading Canadian biotechnology companies working in the field of immune-oncology, announces the closing of the 2nd tranche of its previously announced...

Defence Therapeutics Inc. , a Canadian biopharmaceutical company developing novel immune-oncology therapeutics and drug delivery technologies, is pleased to announce the granting of US patent no....

Defence Therapeutics Inc. , one of the leading Canadian biotechnology companies working in the field of immune-oncology, is pleased to announce the publication of a peer-reviewed study on the...

Defence Therapeutics Inc.  , one of the leading Canadian biotechnology companies working in the field of immune-oncology announces, further to its news release on January 12, 2024, an amendment on...